Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Xigen SA
ClinicalTrials.gov Identifier:
NCT01570205
First received: March 29, 2012
Last updated: April 3, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)